These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


175 related items for PubMed ID: 21466573

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mechanisms of renal NaCl retention in proteinuric disease.
    Svenningsen P, Friis UG, Versland JB, Buhl KB, Møller Frederiksen B, Andersen H, Zachar RM, Bistrup C, Skøtt O, Jørgensen JS, Andersen RF, Jensen BL.
    Acta Physiol (Oxf); 2013 Mar; 207(3):536-45. PubMed ID: 23216619
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Plasmin in nephrotic urine activates the epithelial sodium channel.
    Svenningsen P, Bistrup C, Friis UG, Bertog M, Haerteis S, Krueger B, Stubbe J, Jensen ON, Thiesson HC, Uhrenholt TR, Jespersen B, Jensen BL, Korbmacher C, Skøtt O.
    J Am Soc Nephrol; 2009 Feb; 20(2):299-310. PubMed ID: 19073825
    [Abstract] [Full Text] [Related]

  • 5. Epithelial sodium channel (ENaC) subunit mRNA and protein expression in rats with puromycin aminonucleoside-induced nephrotic syndrome.
    Audigé A, Yu ZR, Frey BM, Uehlinger DE, Frey FJ, Vogt B.
    Clin Sci (Lond); 2003 Apr; 104(4):389-95. PubMed ID: 12653683
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Urokinase-type plasminogen activator contributes to amiloride-sensitive sodium retention in nephrotic range glomerular proteinuria in mice.
    Hinrichs GR, Weyer K, Friis UG, Svenningsen P, Lund IK, Nielsen R, Mollet G, Antignac C, Bistrup C, Jensen BL, Birn H.
    Acta Physiol (Oxf); 2019 Dec; 227(4):e13362. PubMed ID: 31423748
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hyperaldosteronemia and activation of the epithelial sodium channel are not required for sodium retention in puromycin-induced nephrosis.
    Lourdel S, Loffing J, Favre G, Paulais M, Nissant A, Fakitsas P, Créminon C, Féraille E, Verrey F, Teulon J, Doucet A, Deschênes G.
    J Am Soc Nephrol; 2005 Dec; 16(12):3642-50. PubMed ID: 16267158
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mechanisms of sodium retention in nephrotic syndrome.
    Hinrichs GR, Jensen BL, Svenningsen P.
    Curr Opin Nephrol Hypertens; 2020 Mar; 29(2):207-212. PubMed ID: 31789848
    [Abstract] [Full Text] [Related]

  • 17. Urinary plasmin activates collecting duct ENaC current in preeclampsia.
    Buhl KB, Friis UG, Svenningsen P, Gulaveerasingam A, Ovesen P, Frederiksen-Møller B, Jespersen B, Bistrup C, Jensen BL.
    Hypertension; 2012 Nov; 60(5):1346-51. PubMed ID: 22987920
    [Abstract] [Full Text] [Related]

  • 18. Regulation of epithelial sodium channel in puromycin aminonucleoside-induced unilateral experimental nephrotic syndrome in normal and analbuminemic Nagase rats.
    Yu Z, Schumacher M, Frey BM, Frey FJ, Vogt B.
    Nephron Physiol; 2005 Nov; 101(3):p51-62. PubMed ID: 16020936
    [Abstract] [Full Text] [Related]

  • 19. Cathepsin B increases ENaC activity leading to hypertension early in nephrotic syndrome.
    Larionov A, Dahlke E, Kunke M, Zanon Rodriguez L, Schiessl IM, Magnin JL, Kern U, Alli AA, Mollet G, Schilling O, Castrop H, Theilig F.
    J Cell Mol Med; 2019 Oct; 23(10):6543-6553. PubMed ID: 31368174
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.